Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AmacaThera logo — Transforming therapeutics to make a difference in patient he...

AmacaThera

Transforming therapeutics to make a difference in patient health

Founded 2016 Canada Toronto, Canada 14 employees Grant Total: $17.95M Biopharma, Biotechnology +1

General Information

Company Name AmacaThera
Founded Year 2016
Location Canada Toronto, Canada
Employees 14
Industries Biopharma, Biotechnology, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with AmacaThera. To contact AmacaThera, visit amacathera.ca.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AmacaThera compare?

A PDF of AmacaThera and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AmacaThera soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AmacaThera

AmacaThera is a Toronto-based biotechnology company founded in 2016 with a mission to transform therapeutics and make a difference in patient health. The company is focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications in the Biopharma and Biotechnology industries. Under the leadership of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is at the forefront of commercializing combination products at the interface of biomaterials and pharmaceuticals. The company has successfully developed a platform technology to address the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. Their current focus lies on a combination product for post-operative pain, which serves as the company's lead project. AmacaThera recently secured a significant $50.00K grant investment on 01 December 2023 from Toronto Innovation Acceleration Partners, further validating its potential and attracting support for its innovative solutions. Overall, AmacaThera's pioneering technology and recent investment demonstrate its potential to revolutionize therapeutic delivery and make a substantial impact on patient care.

Business keywords: therapeutics, medical applications, injectable hydrogel, platform technology, biomaterials, pharmaceuticals, sustained therapeutic delivery, post-operative pain, Dr. Molly Shoichet, commercialization, innovation, Toronto-based, biomaterials science

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $50.00K 1
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners
01 Dec 2023
Series A $4.00M 6
Inveready MaRS IAF StandUp Ventures
Inveready, MaRS IAF +4
28 Nov 2023
Grant Undisclosed 1
Johnson & Johnson Robotics and Digital Solutions
04 Jan 2023
Series A $10.30M 9
Inveready MaRS IAF StandUp Ventures
Inveready, MaRS IAF +7
22 Feb 2021
Seed Round $3.60M 4
Viva BioInnovator Grey Sky Venture Partners Lumira Ventures
Viva BioInnovator, Grey Sky Venture Partners +2
03 Oct 2019
Seed Round Undisclosed 2
Creative Destruction Lab
Creative Destruction Lab, Ontario Bioscience Industry Organization
01 Jan 2016
Pre Seed Round Undisclosed 1
UTEST
UTEST
01 Jan 2015

AmacaThera Alternatives & Competitors

View All Alternatives
AmacaThera vs
Peptron, Inc.
Peptron, Inc. Korea South

Revolutionizing Patient Care via "Cozy-Cure": Better Treatments, Enhanced Patient Lives

Venture round
20 employees
Biotechnology, Health Care
AmacaThera vs
Titan Pharmaceuticals
Titan Pharmaceuticals United States

Titan Pharmaceuticals Inc. is developing proprietary therapeutics primarily for the treatment of ser...

Post-IPO Equity
33 employees
Biotechnology, Health and Wellness
AmacaThera vs
Serina Therapeutics, Inc.
Serina Therapeutics, Inc. United States

We have the next generation in polymer therapeutics. Go to www.serinatherapeutics.com and explore ou...

Grant
15 employees
Biopharma, Biotechnology
Also compare with: AmacaThera vs Heron Therapeutics, Inc. Heron Therapeutics, Inc. View all alternatives

FAQ About AmacaThera

Transforming therapeutics to make a difference in patient health
AmacaThera was founded in 2016.
AmacaThera is headquartered in Toronto, Canada.
AmacaThera operates in Biopharma, Biotechnology and Health and Wellness. Its work centres on therapeutics, medical applications, injectable hydrogel and platform technology.
AmacaThera has approximately 14 employees.
AmacaThera has completed 7 funding rounds, raising a total of $17.95M. The latest funding stage is Grant.
Top alternatives and competitors to AmacaThera include Peptron, Inc., Titan Pharmaceuticals, Serina Therapeutics, Inc., Heron Therapeutics, Inc., ImmunAbs Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AmacaThera and Peptron, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AmacaThera, https://bouncewatch.com/company/amacathera, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes